Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$48.64 - $62.51 $257,792 - $331,303
5,300 New
5,300 $297,000
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $214,416 - $275,760
3,600 New
3,600 $225,000
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $195,039 - $286,065
3,900 New
3,900 $219,000
Q4 2020

Feb 12, 2021

SELL
$42.19 - $51.5 $383,929 - $468,650
-9,100 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$35.33 - $51.04 $105,990 - $153,120
-3,000 Reduced 24.79%
9,100 $449,000
Q2 2020

Aug 13, 2020

SELL
$22.91 - $39.83 $112,259 - $195,167
-4,900 Reduced 28.82%
12,100 $417,000
Q1 2020

May 11, 2020

SELL
$16.44 - $37.73 $49,320 - $113,189
-3,000 Reduced 15.0%
17,000 $404,000
Q4 2019

Feb 12, 2020

BUY
$19.57 - $28.96 $391,400 - $579,200
20,000 New
20,000 $543,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.